1. Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers. (2nd February 2022) Authors: Garmezy, Benjamin; Gheeya, Jinesh; Lin, Heather Y.; Huang, Yuefan; Kim, Taebeom; Jiang, Xianli; Thein, Kyaw Z.; Pilié, Patrick G.; Zeineddine, Fadl; Wang, Wanlin; Shaw, Kenna R.; Rodon, Jordi; Shen, John Paul; Yuan, Ying; Meric-Bernstam, Funda; Chen, Ken; Yap, Timothy A. Journal: JCO precision oncology Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Germline genetic variants in men with prostate cancer and one or more additional cancers. Issue 20 (28th June 2017) Authors: Pilié, Patrick G.; Johnson, Anna M.; Hanson, Kristen L.; Dayno, Megan E.; Kapron, Ashley L.; Stoffel, Elena M.; Cooney, Kathleen A. Journal: Cancer Issue: Volume 123:Issue 20(2017) Page Start: 3925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial. Issue 3 (March 2022) Authors: Smith, Matthew R; Scher, Howard I; Sandhu, Shahneen; Efstathiou, Eleni; Lara, Primo N; Yu, Evan Y; George, Daniel J; Chi, Kim N; Saad, Fred; Ståhl, Olof; Olmos, David; Danila, Daniel C; Mason, Gary E; Espina, Byron M; Zhao, Xin; Urtishak, Karen A; Francis, Peter; Lopez-Gitlitz, Angela; Fizazi, Ka... Journal: Lancet oncology Issue: Volume 23:Issue 3(2022) Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗